NovoCure
NVCR
NVCR
225 hedge funds and large institutions have $1.49B invested in NovoCure in 2023 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 74 increasing their positions, 62 reducing their positions, and 81 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
15% less funds holding
Funds holding: 265 → 225 (-40)
47% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 81
61% less capital invested
Capital invested by funds: $3.78B → $1.49B (-$2.29B)
Holders
225
Holding in Top 10
2
Calls
$23.8M
Puts
$13.3M
Top Buyers
| 1 | +$40.4M | |
| 2 | +$24M | |
| 3 | +$13.8M | |
| 4 |
Two Sigma Investments
New York
|
+$13.1M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$12.7M |
Top Sellers
| 1 | -$78.5M | |
| 2 | -$40.6M | |
| 3 | -$30.3M | |
| 4 |
HIC
Hartline Investment Corp
Winnetka,
Illinois
|
-$13.1M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$9.65M |